A medic at Burjeel Hospital in downtown Abu Dhabi holds a dose of a vaccine developed by Chinese drug maker Sinopharm. Victor Besa / The National
A medic at Burjeel Hospital in downtown Abu Dhabi holds a dose of a vaccine developed by Chinese drug maker Sinopharm. Victor Besa / The National
Burjeel IPO: UAE healthcare provider may raise as much as $368m from offering
The subscription period for the offering runs from September 30 to October 4 for both retail and professional investors
